A Growing Market Opportunity

• The global healthcare AI market is projected to reach $34 billion by 2030, fueled by the increasing demand for AI-powered diagnostics.
• Our flagship products, mCR (Chest Radiography AI) and mCT (CT Imaging AI), position us to capture a significant market share.

Proven Track Record

• Processed 100,000+ imaging studies, validating our technology in real-world clinical environments.

Strategic Partnerships

• Collaborating with leading healthcare institutions and diagnostic centers across India.
• Expanding into international markets like Africa and Southeast Asia.
• Co-developing proprietary AI models through clinical validation partnerships.

Strong Growth Potential

• Our flagship products, mCR (Chest Radiography AI) and mCT (CT Imaging AI), position us to capture a significant market share.

Innovative Technology

• Proprietary AI tools for automated diagnostic reporting, covering 20+ pathologies, including lung cancer and tuberculosis.
• Seamless integration with PACS and reporting systems, providing cost-effective solutions for healthcare providers.